Glioblastoma
-
Predicting brain cancer outcome
Red blood cell distribution width has prognostic value for many diseases, but it was not associated with overall survival in patients with glioblastoma, Vanderbilt researchers found. Read MoreFeb 15, 2022
-
MRI view of brain tumor prognosis
In patients with glioblastoma brain tumors, features detected on MRIs at diagnosis were associated with survival, Vanderbilt Medical Center investigators found. Read MoreFeb 22, 2021
-
Discovery of aggressive cancer cell types by Vanderbilt researchers made possible with machine learning techniques
Rebecca Ihrie and Jonathan Irish are leading the development of machine learning applications for brain cancer research. Read MoreJun 24, 2020
-
Drug combos for glioblastoma
Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment. Read MoreMay 3, 2016
-
New approach may halt glioblastoma’s ability to grow
Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer. Read MoreJan 16, 2014
-
New drugs a good BET for brain cancer
A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. Read MoreMar 20, 2013
-
Brain tumor TIP reveals new target
The protein TIP-1 appears to be a novel prognostic marker for glioblastoma and may be a good therapeutic target for disrupting tumor-driven blood vessel development. Read MoreFeb 4, 2013
-
Network approach yields glioblastoma clues
MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor. Read MoreAug 9, 2012